Keyword: Biotechnology

News

CDT to Commercialize Veterinary Cancer Drug

07.12.2015 - Spotlight Innovation, a venture capital-backed holding company specialized in identifying, acquiring and nurturing companies that have unique intellectual property in the medical...

News

Korean Drug Specialists Collaborate on Cancer Therapy

23.11.2015 - Singapore-based biotechnology firm Aslan Pharmaceuticals, which specializes in immunotherapy and targeted agents for cancer forms prevalent in Asia, has agreed to cooperate with...

News

DuPont to Buy Dyadic Biotech Assets

12.11.2015 - DuPont Industrial Biosciences is paying $75 million to acquire the enzyme and technology assets of Dyadic, a financially struggling US biotech firm based at Jupiter, Florida. The...

News

Shire to Buy Biotech Firm Dyax

04.11.2015 - Ireland-based and London-listed drugmaker Shire has agreed what is being called a “defensive” deal to buy US biotech firm Dyax, which has a breakthrough drug said to threaten one...

Sites & Services

Quality and Reliability

28.10.2015 - The Swiss chemical industry has been dominated by worry and uncertainty in 2015. In 2011, the industry was severely affected by the downturn in the global economy and the...

Sites & Services

Bavaria’s “Region of Renewable Raw Materials”

28.10.2015 - Straubing is the Region of Renewable Raw Materials. Here, the Free State of Bavaria is clustering its activities and expertise regarding research, education, innovation...

Markets & Companies

Biohybrid Chemistry Cluster

28.10.2015 - Since the discovery of large oil reserves in the late 1850s, Ontario’s chemical industry has steadily grown, turning the province into a global hub for the petrochemical industry...

News

Biogen to Cut Staff, Focus on Oral MS Drug

27.10.2015 - Biogen has announced a corporate restructuring scheme that will lead it to terminate a number of drug pipeline programs while cutting the workforce by 11% up to the end of this...